News

In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discusses ...
So far, China has made no official public threat about weaponizing its dominant position in this segment of the ...
Billions of dollars worth of U.S. biomanufacturing plant development has been announced, and site selection will likely be ...
Ratcheting up the tariff rhetoric has consistently sent the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average into a tailspin. However, whenever President Trump has chosen to reverse course, ...
Earnings warnings, billion-dollar pivots, and vanishing guidance--how looming Trump-era tariffs could upend global business ...
About 15% of colon cancers are dMMR, which confers resistance to chemotherapy. ICIs have FDA approval for metastatic dMMR ...
Odin Industries is proud to announce the acquisition of Florida based A Doc on Wheels, a respected provider of mobile medical services. Effective June 3, 2025, the company will be rebranded as Shield ...
Explore Faiz Siddiqui’s gripping portrayal of Elon Musk's rise through Tesla, Twitter, and tech disruption. From self-driving ...
Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...
Financial Stability: Eli Lilly's balance sheet is more robust, with debt making up only 4% of equity, considerably less than ...